1209 IMPACT OF EARLY RESPONSE DEFINITIONS ON DURATION AND OUTCOME OF TREATMENT WITH BI201335 PLUS PR von Sulkowski, M, Asselah, T, Ferenci, P, Stern, J.O, Kukolj, G, Bocher, W.O, Scherer, J

Volltext

1185 CHARACTERIZATION OF HCV NS3 VARIANTS THAT EMERGED DURING VIROLOGIC BREAKTHROUGH AND RELAPSE FROM BI 201335 PHASE II SILEN-C2 STUDY IN PEGIFN/RBV TREATMENT-EXPERIENCED PATIENTS von Kukolj, G, Bethell, R, Cartier, M, Cote-Martin, A, Lagace, L, Marquis, M, Triki, I, Sulkowski, M, Asselah, T, Lalezari, J, Ferenci, P, Bocher, W.O, Datsenko, Y, Nehmiz, G, Scherer, J, Steinmann, G, Stern, J.O

Volltext

1212 PHARMACOKINETIC MODELLING OF THE RELATIONSHIP BETWEEN SUSTAINED VIROLOGICAL RESPONSE AND PLASMA CONCENTRATIONS OF FALDAPREVIR OR BI-207127 IN HCV GT1-INFECTED PATIENTS IN SOUN... von Olson, S, Baron, K, Riggs, M, Böcher, W.O, Mensa, F.J

Volltext

1227 AN ANALYSIS OF RESPONSE RATES BY FIBROSIS STAGE IN PATIENTS TREATED WITH FALDAPREVIR, BI 207127 AND RIBAVIRIN IN THE SOUND-C2 STUDY von Zeuzem, S, Soriano, V, Asselah, T, Bronowicki, J.-P, Lohse, A.W, Müllhaupt, B, Schuchmann, M, Bourliere, M, Buti, M, Roberts, S, Gane, E, Stern, J.O, Voss, F, Baum, P, Gallivan, J.-P, Böcher, W.O, Mensa, F.J

Volltext

1186 ITPA GENE VARIANTS PREDICT HEMOLYTIC RIBAVIRIN INDUCED ANAEMIA IN PATIENTS TREATED WITH THE INTERFERON-FREE REGIMEN OF FALDAPREVIR, BI 207127 AND RIBAVIRIN IN SOUND-C2 von Asselah, T, Zeuzem, S, Soriano, V, Bronowicki, J.-P, Lohse, A.W, Müllhaupt, B, Schuchmann, M, Bourliere, M, Buti, M, Roberts, S, Gane, E, Stern, J.O, Voss, F, Baum, P, Gallivan, J.-P, Böcher, W.O, Mensa, F.J

Volltext

101 SVR4 AND SVR12 WITH AN INTERFERON-FREE REGIMEN OF BI201335 AND BI207127, +/- RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE-1 HCV INFECTION: INTERIM RESULTS OF SO... von Zeuzem, S, Soriano, V, Asselah, T, Bronowicki, J.-P, Lohse, A, Müllhaupt, B, Schuchmann, M, Bourliere, M, Buti, M, Roberts, S, Gane, E, Stern, J.O, Kukolj, G, Dai, L, Böcher, W.O, Mensa, F.J

Volltext

Retreatment with high vs. conventional doses of consensus interferon and ribavirin of patients with non-response or relapse after previous treatment with alpha-interferon von Bocher, W.O., Galle, P.R., Löhr, H.F.

Volltext

Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection von Tavakoli, S, Mederacke, I, Herzog-Hauff, S, Glebe, D, Grün, S, Strand, D, Urban, S, Gehring, A, Galle, P.R, Böcher, W.O

Volltext

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase... von Feagan, B.G, Sandborn, W.J, D'Haens, G, Panés, J, Kaser, A, Ferrante, Marc, Louis, E, Franchimont, D, Dewit, O, Seidler, U, Kim, K.J, Neurath, M.F, Schreiber, S, Scholl, P, Pamulapati, C, Lalovic, B, Visvanathan, S, Padula, S.J, Herichova, I, Soaita, A, Hall, D.B, Böcher, W.O

Volltext

164 Hepatitis C virus infection after liver transplantation - early and dose escalating antiviral therapy with interferon alpha and ribavirin increases tolerability without losing... von Schuchmann, M., Greif-Higer, G., Wunsch, M., Mönch, C., Barreiros, A.P., Elke, B., Böcher, W.O., Kanzler, S., Galle, P.R., Lohse, A.W., Otto, G.

Volltext

Functional defect of dendritic cells in chronic HBV infection von Böcher, W.O., Rohwer, A., Hofmann, S., Galle, P.R., Löhr, H.F.

Volltext

How long to treat chronic hepatitis B virus infection with lamivudine? von Löhr, H F, Schlaak, J F, Lohse, A W, Böcher, W O, Kanzler, S, Ibe, M, Galle, P R

Volltext